Skip to content

Intraoperative TIVA With Propofol on Postoperative Pain and Side Effects After Liver Resection Surgery

Retrospective Study to Investigate Intraoperative TIVA With Propofol on Postoperative Pain and Side Effects After Liver Resection Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02179437
Enrollment
95
Registered
2014-07-01
Start date
2014-08-01
Completion date
2016-02-22
Last updated
2024-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

TIVA, Propofol, Postoperative pain, Liver resection surgery, Retrospective study

Brief summary

Postoperative pain can be severe after liver resection surgery. However, postoperative pain management may be difficult for this group of patients. Opioidergic neurotransmission may be altered in cirrhotic patients and selectively increasing receptor affinity for opioids. Large dose of strong opioid may be required to achieve adequate pain control. However, this may not be possible due to the side effect of opioid and liver dysfunction after liver resection. Propofol is a commonly used anaesthetic with rapid recovery and less side effects and TIVA (total intravenous analgesia) with propofol is a common technique now. The reduction on certain serum pro- inflammatory cytokines may lead to more smooth post- surgical recovery. Recent case report proved the analgesic effect of propofol infusion. However other animal and clinical studies showed controversial result. The aim of this retrospective study is to investigate the postoperative analgesic effects and side effects of intraoperative TIVA with propofol in patient undergoing liver resection surgery at Queen Mary Hospital, Hong Kong between 2010 to 2012.

Detailed description

Retrospective audit. Anaesthetic records and acute pain service records of patient undergone liver resection surgery between 2010 to 2012 in Queen Mary Hospital would be retrieved from the computer. Data Collection 1. Demographic data; 2. Types of analgesic techniques; 3. Type of pain relief modalities; 4. Pain score up to 72 hours postoperatively; 5. Postoperative opioid consumption; 6. Incidence of adverse events during APS care; 7. Patients' satisfaction on pain relief. Data Analysis For summarising analysis, mean or median with standard deviation or interquartile range will be reported. Parametric and non-parametric comparative tests will be used for analysis between/among patients with various characteristics. Kaplan Meier survival analysis and log-rank test will be used for duration of APS use.

Interventions

None listed

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient undergone liver resection surgery between 2010 to 2012 in Queen Mary Hospital

Exclusion criteria

* Essential data were missing. * Patient participating in other research projects. * Changes in postoperative pain management technique. * Patients could not be assessed post-operatively for pain (i.e. post-operative IPPV)

Design outcomes

Primary

MeasureTime frame
Postoperative pain scoreFrom postoperative 1 hour to postoperative 72 hour

Secondary

MeasureTime frame
Adverse eventFrom postoperative 1 hour to postoperative 72 hour

Other

MeasureTime frame
Analgesic consumptionFrom postoperative 1 hour to postoperative 72 hour

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026